Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
ACORN BIOVENTURES, L.P.
10% owner at OnKure Therapeutics. Filing since 15 May 2025.
CIK 0001766853
Company
Date
Role
Action
Shares
Amount
Of holding
OKUR
OnKure Therapeutics, Inc.
15 May 2025
10% owner
Bought
1,129,730
$2.09M
opened
OKUR
OnKure Therapeutics, Inc.
15 May 2025
10% owner
Bought
270,270
$500.00K
18.8%
2 decisions on file.
